BioSpace News Archive

Drug Development

Moderna’s Q4 Shows a Company Bursting at the Seams With Activity

Coming off its record-breaking initial public offering (IPO) in December, where it raised $604.3 million, Moderna released its fourth-quarter financials, outlining an ambitious company buzzing with activity.

March 6, 2019
·
3 min read
·
Mark Terry
Deals

Bristol-Myers Squibb Strikes Back! Response to Critics of Celgene Deal

Bristol-Myers Squibb announced its bid to acquire Celgene on January 3, 2019. However, the deal hit a snag. Bristol-Myers Squibb is now fighting back, making efforts to sell the deal to its shareholders.

March 6, 2019
·
3 min read
·
Mark Terry
Deals

Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2027

Exact Sciences Corporation announced today that it has priced its underwritten public offering of 0.3750% convertible senior notes due 2027 (the “Notes”) and upsized the offering from $600 million to $650 million aggregate principal amount.

March 6, 2019
·
5 min read
Business

Brenntag Reports Strong Growth in Financial Year 2018 With an All-time High in Operating EBITDA

Brenntag posted a good financial year 2018. Its two KPIs operating gross profit and operating EBITDA both showed a clear increase due primarily to good organic growth.

March 6, 2019
·
2 min read
Biotech Beach

Blue Shield of California Provides Nearly $2 Million to Support Health Care and Community Services for Wildfire Victims

Blue Shield helps doctors resume care for patients; rebuild destroyed clinic

March 6, 2019
·
6 min read
Business

Sectra’s Nine-month Interim Report 2018/2019: Sectra is Growing With Satisfied Customers - Tops Ranking for Sixth Consecutive Year

Sectra is growing in the medical IT and cybersecurity markets.

March 6, 2019
·
4 min read
Tilray® Announces Successful Medical Cannabis Harvest in Portugal and Provides Update on Rapidly Expanding European Operations

Tilray, Inc. today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”) has completed a successful harvest of medical cannabis at the Company’s European Union (EU) Campus in Portugal.

March 6, 2019
·
4 min read
Policy

Brain & Behavior Research Foundation Comments on FDA Approval of New Depression Treatment

The Brain & Behavior Research Foundation (BBRF) applauds the FDA for its approval of Esketamine nasal spray as a new medication for treatment of resistant depression.

March 6, 2019
·
2 min read
c-LEcta develops highly efficient manufacturing process for active cosmetic ingredient

New and highly efficient manufacturing process for an active ingredient for body care products and decorative cosmetics

March 6, 2019
·
3 min read
Policy

FDA Accepts Genentech’s Supplemental New Drug Application for XOFLUZA (baloxavir marboxil) for the Treatment of Influenza in People at High Risk of Complications

XOFLUZA would be the first antiviral medicine approved specifically for the high-risk population

March 6, 2019
·
8 min read